- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Study Reveals How Obesity in Pregnancy Triggers Liver Disorders in Offspring - Video
Overview
Children born to obese mothers may face an increased risk of developing metabolic disorders, even when they follow a healthy diet themselves. A new study published in Nature by researchers at the University of Bonn offers a compelling explanation: in obese mice, maternal obesity reprograms immune cells in the embryo’s liver, causing lasting disruptions to metabolic function in the offspring.
The study focused on Kupffer cells, a specialized type of macrophage that takes up permanent residence in the liver during embryonic development. These cells play a critical role not only in immune defense but also in regulating liver metabolism. “They instruct the surrounding liver cells on what to do,” explains Prof. Dr. Elvira Mass from the LIMES Institute at the University of Bonn. “In this way, they help ensure that the liver, as a central metabolic organ, performs its many tasks correctly.”
The researchers found that offspring of obese mouse mothers developed fatty liver disease shortly after birth—even when fed a normal diet. The team discovered that metabolic products from the mother activate a transcription factor in Kupffer cells during pregnancy, reprogramming them to send signals that promote fat accumulation in the liver.
To test whether this reprogramming could be reversed, the researchers genetically removed the transcription factor during pregnancy. As a result, the offspring did not develop fatty liver disease, offering a promising direction for future treatment strategies. Whether this pathway can be targeted with medication remains to be seen, and follow-up studies are underway.
“This switch is a so-called transcription factor. It controls which genes are active in Kupffer cells,” said Mass, emphasizing the precision of this molecular mechanism. The implications are far-reaching: early changes in liver programming may set the stage for lifelong health challenges.
Reference: Huang, H., Balzer, N.R., Seep, L. et al. Kupffer cell programming by maternal obesity triggers fatty liver disease. Nature (2025). https://doi.org/10.1038/s41586-025-09190-w
Speakers
Dr. Bhumika Maikhuri
BDS, MDS